« Advances in Steinert’s disease » and « Advances in myotonic dystrophy type 2 » are two new documents, published by the French Muscular Dystrophy Association (AFM-Téléthon), which can be downloaded.
Steinert’s disease or myotonic dystrophy type 1 is a rare disease of genetic origin. It affects the muscles, which become weak (dystrophy) and difficult to relax after contraction (myotonia). It also affects other organs (heart and respiratory systems, digestive system, hormone secretions and nervous system): it is a so-called multisystem disease.
« Advances in Steinert’s disease » presents research news in myotonic dystrophy type 1 field : international symposia, ongoing clinical trials or studies, scientific and medical publications…
It has been translated into English from “Avancées dans la maladie de Steinert”, published by the French Muscular Dystrophy Association (AFM-Téléthon) in june 2020.
Download the document « Advances in Steinert’s disease »
Myotonic dystrophy type 2 or PROMM (Proximal Myotonic Myopathy) is a rare disease of genetic origin. It affects the muscles, which become weak (dystrophy) and difficult to relax after contraction (myotonia). It can also affect other organs (heart, eyes, etc.). It manifests in adulthood and progresses slowly. This disease has many similarities with another, much more common neuromuscular disease, Steinert’s disease (or myotonic dystrophy type 1).
« Advances in myotonic dystrophy type 2 » presents research news in myotonic dystrophy type 2 field : international symposia, ongoing clinical trials or studies, scientific and medical publications, etc.
It has been translated into English from “Avancées dans la dystrophie myotonique de type 2”, published by the French Muscular Dystrophy Assocation (AFM-Téléthon) in june 2020.
Download the document « Advances in myotonic dystrophy type 2 »
